-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Every year, many patients are admitted to the emergency room for suspected acute ischemic stroke (AIS)
Therefore, this article compares the long-term prognosis of patients with FSM and patients with mild AIS
This single-center retrospective cohort study was conducted at the University Medical Center of Groningen
This single-center retrospective cohort study was conducted at the University Medical Center of Groningen
Participants used the Clinical Global Impression Improvement (CGI-I) Scale and CGI Severity (CGI-S) Scale to score their changes in symptoms and the severity of symptoms at admission and follow-up
116 patients agreed to participate, of which 38 patients were diagnosed with FSM and 78 patients were diagnosed with mild AIS
A) Clinical overall impression improvement scale (B) Clinical overall impression severity scale
At follow-up, FSM patients scored significantly lower in several sub-areas of RAND-36: social function (median 56 (IQR 50-75) vs 75 (IQR 63-88); p=0.
During follow-up, FSM patients scored significantly lower in several sub-areas of RAND-36: During follow-up, FSM patients scored significantly lower in several sub-areas of RAND-36:
Compared with patients with mild AIS, the self-evaluated long-term prognosis of FSM patients is worse
Compared with patients with mild AIS, the self-evaluated long-term prognosis of FSM patients is worse
Given that 80% of FSM patients have persistent symptoms and have a significant impact on the quality of life, it can be considered that the prognosis of FSM is poor
Given that 80% of FSM patients have persistent symptoms and have a significant impact on the quality of life, it can be considered that the prognosis of FSM is poor
Leave a message here